TG Therapeutics, Inc. (NASDAQ:TGTX) shares climbed in Tuesday’s extended trading after the company released its preliminary fourth quarter revenue estimates and provided an optimistic outlook for 2026. Here’s a look at the details.

  • TGTX stock is climbing. See the chart and price action here.

TG Therapeutics said it expects …

Full story available on Benzinga.com